Small bowel endoscopic bariatric therapies

키워드

참고문헌 (35)

1. Adams KF, "Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old", N Engl J Med, 355, pp.763~778 (2006)[DOI]
2. Rubino F, "The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes", Ann Surg, 244, pp.741~749 (2006)[DOI]
3. Schauer PR, "Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes", N Engl J Med, 376, pp.641~651 (2017)[DOI]
4. Mingrone G, "Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial", Lancet, 386, pp.964~973 (2015)[DOI]
5. Sullivan S, "Endoscopic bariatric and metabolic therapies: new and emerging technologies", Gastroenterology, 152, pp.1791~1801 (2017)[DOI]
6. Jirapinyo P, "Endoscopic bariatric and metabolic therapies: surgical analogues and mechanisms of action", Clin Gastroenterol Hepatol, 15, pp.619~630 (2017)[DOI]
7. Machytka E, "Partial jejunal diversion using an incisionless magnetic anastomosis system: 1-year interim results in patients with obesity and diabetes", Gastrointest Endosc, 86, pp.904~912 (2017)[DOI]
8. Rubino F, "Potential of surgery for curing type 2 diabetes mellitus", Ann Surg, 236, pp.554~559 (2002)[DOI]
9. Pories WJ, "Etiology of type II diabetes mellitus: role of the foregut", World J Surg, 25, pp.527~531 (2001)[DOI]
10. Rubino F, "The early effect of the Rouxen-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism", Ann Surg, 240, pp.236~242 (2004)[DOI]
11. Cummings DE, "Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution", J Clin Endocrinol Metab, 89, pp.2608~2615 (2004)[DOI]
12. Mason EE, "The mechanisms of surgical treatment of type 2 diabetes", Obes Surg, 15, pp.459~461 (2005)[DOI]
13. Patriti A, "The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery", Obes Surg, 14, pp.840~848 (2004)[DOI]
14. transposition and enteroglucagon, "GLP-1 in obesity (and diabetic?) surgery", Obes Surg, 9, pp.223~228 (1999)[DOI]
15. Maljaars PW, "Ileal brake: a sensible food target for appetite control. A review", Physiol Behav, 95, pp.271~281 (2008)[DOI]
16. Cohen R, "Role of proximal gut exclusion from food on glucose homeostasis in patients with type 2 diabetes", Diabet Med, 30, pp.1482~1486 (2013)[DOI]
17. Dixon JB, "Bariatric surgery for type 2 diabetes", Lancet, 379, pp.2300~2311 (2012)[DOI]
18. Meek CL, "The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones", Peptides, 77, pp.28~37 (2016)[DOI]
19. Jirapinyo P, "Effect of the duodenal-jejunal bypass liner on glycemic control in patients with type 2 diabetes with obesity: a meta-analysis with secondary analysis on weight loss and hormonal changes", Diabetes Care, 41, pp.1106~1115 (2018)[DOI]
20. Rodriguez L, "Pilot clinical study of an endoscopic, removable duodenal-jejunal bypass liner for the treatment of type 2 diabetes", Diabetes Technol Ther, 11, pp.725~732 (2009)[DOI]
21. Tarnoff M, "Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery", Surg Endosc, 23, pp.650~656 (2009)[DOI]
22. Gersin KS, "Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates", Gastrointest Endosc, 71, pp.976~982 (2010)[DOI]
23. Schouten R, "A multicenter, randomized efficacy study of the EndoBarrier gastrointestinal liner for presurgical weight loss prior to bariatric surgery", Ann Surg, 251, pp.236~243 (2010)[DOI]
24. Koehestanie P, "The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial", Ann Surg, 260, pp.984~992 (2014)[DOI]
25. ASGE Bariatric Endoscopy Task Force, "ASGE bariatric endoscopy task force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies", Gastrointest Endosc, 82, pp.425~438 (2015)[DOI]
26. Rohde U, "Effect of the EndoBarrier gastrointestinal liner on obesity and type 2 diabetes: a systematic review and meta-analysis", Diabetes Obes Metab, 18, pp.300~305 (2016)[DOI]
27. Betzel B, "Changes in glycemic control and body weight after explantation of the duodenal-jejunal bypass liner", Gastrointest Endosc, 85, pp.409~415 (2017)[DOI]
28. Forner PM, "Safety and effectiveness of an endoscopically placed duodenal-jejunal bypass device (<TEX>$EndoBarrier^{(R)}$<", TEX>): outcomes in 114 patients, 2017, pp.27, 3306~3313
29. Betzel B, "Safety experience with the duodenal-jejunal bypass liner: an endoscopic treatment for diabetes and obesity", Gastrointest Endosc, 82, pp.845~852 (2015)[DOI]
30. Quezada N, "Safety and efficacy of the endoscopic duodenal-jejunal bypass liner prototype in severe or morbidly obese subjects implanted for up to 3 years", Surg Endosc, 32, pp.260~267 (2018)[DOI]
31. Sandler BJ, "Human experience with an endoluminal, endoscopic, gastrojejunal bypass sleeve", Surg Endosc, 25, pp.3028~3033 (2011)[DOI]
32. Sandler BJ, "One-year human experience with a novel endoluminal, endoscopic gastric bypass sleeve for morbid obesity", Surg Endosc, 29, pp.3298~3303 (2015)[DOI]
33. Ryou M, "Minimally invasive entero-enteral dual-path bypass using self-assembling magnets", Surg Endosc, 30, pp.4533~4538 (2016)[DOI]
34. Machytka E, "Endoscopic dual-path enteral anastomosis using self-assembling magnets: first-inhuman clinical feasibility", Gastroenterology, 150(4 Suppl 1), pp.S232~ (2016)
35. Rajagopalan H, "Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes: 6-month interim analysis from the first-in-human proof-of-concept study", Diabetes Care, 39, pp.2254~2261 (2016)[DOI]

관련 논문AI추천